Advances & Updates

PNOC PUBLICATION!

PNOC001: Phase II Study of Everolimus For Recurrent or Progressive Low-Grade Gliomas in Children , November 17, 2023

Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial